OakChart

Petmed Express Inc

PETSHealthcare·Pharmaceutical Retailers·USA·Nano·NASD·Nov 10 • 3:59 PM ET

1.210.00 (0.00%)
2026-11-11 14:42 CET
Market cap
26.23 USD m
Revenue, TTM
160.26 USD m
Net income, TTM
-27.19 USD m
Free cash flow, TTM
-24.62 USD m
EPS diluted, TTM
-1.28
P/E
-
Compare

Price

PETS against its 20, 50 and 200-day averages
2050200earnings
1.502.002.5013.8M27.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PETSclose 1.2120-day 1.2050-day 1.40200-day 2.041.21

70.5% under 4.10 on 16 Dec 2025. Last 15 sessions, 11.7% high to low

Profile

PETS
52-week range, 2% of the way up
1.154.10

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs, cats, and horses. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Employees189
IPOApr 26, 1999
Beta0.82
ATR, 14d0.05
Rel volume0.00
Short float5.76%
Insider own33.61%
Inst own22.48%

Snapshot

6 groups

Valuation

Index-
Market Cap26.23M
Enterprise Value15.11M
Income-27.19M
Sales160.26M
Book/sh0.76
Cash/sh0.53
Dividend Est.-
Dividend TTM-
Dividend Ex-DateAug 11, 2023
Dividend Gr. 3/5Y- -
Payout-
Employees189
IPOApr 26, 1999

Ratios

P/E-
Forward P/E-
PEG-
P/S0.16
P/B1.59
P/C2.30
P/FCF-
EV/EBITDA-
EV/Sales0.09
Quick Ratio0.45
Current Ratio0.60
Debt/Eq0.02
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.28
EPS next Y-0.35
EPS next Q-0.16
EPS this Y81.75%
EPS next Y30.00%
EPS next 5Y49.64%
EPS past 3/5Y- -
Sales past 3/5Y-11.31% -10.35%
EPS Y/Y TTM34.91%
Sales Y/Y TTM-17.81%
EPS Q/Q25.15%
Sales Q/Q-19.37%
EarningsNov 10 AMC
EPS/Sales Surpr.-181.82% -

Ownership

Insider Own33.61%
Insider Trans0.34%
Inst Own22.48%
Inst Trans-8.29%
ROA-34.05%
ROE-90.76%
ROIC-161.27%
Gross Margin22.08%
Oper. Margin-17.98%
Profit Margin-16.97%
SMA200.83%
SMA50-13.60%
SMA200-40.65%
Trades-

Technical

Shs Outstand22.13M
Shs Float14.39M
Short Float5.76%
Short Ratio7.39
Short Interest0.83M
52W High4.10 -70.49%
52W Low1.15 5.22%
Volatility4.36% 4.18%
ATR (14)0.05
RSI (14)40.80
Beta0.82
Rel Volume0.00
Avg Volume112.32K
Volume0

Performance

Perf Week0.83%
Perf Month-3.97%
Perf Quarter-39.80%
Perf Half Y-45.50%
Perf YTD-62.19%
Perf Year-53.64%
Perf 3Y-83.15%
Perf 5Y-95.91%
Perf 10Y-94.15%
Recom5.00
Target Price1.40
Prev Close1.21
Price1.21
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 25, 2023InitiatedLLake StreetBuy$20+1,552.9%
Jan 20, 2022UpgradeSSidotiNeutral → Buy$32+2,544.6%
Nov 18, 2021InitiatedMMorgan StanleyUnderweight$25+1,966.1%
Oct 01, 2021InitiatedJJefferiesHold$28+2,214.0%
Aug 05, 2021ResumedCCredit SuisseUnderperform$22+1,718.2%
Jun 03, 2021DowngradeSSidotiBuy → Neutral$39+3,123.1%
Mar 05, 2021UpgradeSSidotiNeutral → Buy
Jan 27, 2021DowngradeSSidotiBuy → Neutral
Aug 19, 2020UpgradeSSidotiNeutral → Buy$37 → $41+3,288.4%
Apr 09, 2020DowngradeSSidotiBuy → Neutral

Peers

Mkt cap
TickerCompanyMkt cap
CHWYChewy Inc9.16B
POMPomdoctor Ltd12.84M
WOOFPetco Health and Wellness Co Inc839.21M
LFMDLifeMD Inc84.35M
BARKBARK Inc83.59M
GDRXGoodRx Holdings Inc1.19B
HIMSHims & Hers Health Inc4.54B
ELANElanco Animal Health Inc13.20B
CENTCentral Garden & Pet Co2.66B
TRUPTrupanion Inc1.47B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
NINA CAPITAL HOLDINGS INC.10% OwnerJun 08 '26Buy1.7525,00043,7252,600,000Jun 09 05:06 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
VXFVanguard Extended Market Index ETFAUM: 30.61B
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
IWCiShares Micro-Cap ETFAUM: 1.23B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 112.22M

News

latest 14 of 206
  • PetMed Express Misses As Cost Cuts Narrow The Loss But Sales Stabilization Breaks (Earnings Whispers)
  • PetMed: Fiscal Q2 Earnings Snapshot (Associated Press)
  • PetMeds Announces Second Quarter Financial Results (GlobeNewswire)
  • PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels (GlobeNewswire)
  • PetMed Express Faces Cash And Sales Test As Stock Trades Far Below $3 Bid (Earnings Whispers)
  • Loading…
  • PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026 (GlobeNewswire)
  • PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
  • PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director (GlobeNewswire)
  • PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition (GlobeNewswire)
  • PetMeds Appoints Andrew Parry as Chief Technology Officer (GlobeNewswire)
  • PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ... (GuruFocus.com) -10.10%
  • PetMed: Fiscal Q1 Earnings Snapshot (Associated Press)
  • PetMeds Announces First Quarter Financial Results (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-11-10-0.310-0.110-0.30535.77-1
2026Q12026-08-13-0.2800.120-0.28341.02-1
2025Q42026-06-02-0.190-0.180-0.19342.82-1
2025Q32026-01-27-0.500-0.060-0.50252.98-1
2025Q22025-10-270.0400.040-0.40852.98-1
2025Q12025-07-28-0.070-0.020-1.64552.9869.311
2024Q42025-07-01-0.490-0.340-0.56451.1051.102
2024Q32025-02-10-0.0300.005-0.03452.9860.002
2024Q22024-11-060.110-0.0550.11159.5766.002
2024Q12024-08-060.180-0.0900.17967.9575.002
2023Q42024-06-11-0.250-0.070-0.24566.5065.001
2023Q32024-04-15-0.100-0.010-0.09965.3265.002
2023Q22023-10-300.0000.0850.03471.0076.002
2023Q12023-07-31-0.0400.073-0.04478.2479.953
2022Q42023-05-22-0.2500.137-0.25162.4165.753
2022Q32023-02-060.0000.197-0.00158.8762.033

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY1.8201.7951.825273.8274.89
2018FY1.8401.9831.842283.42287.91
2019FY1.2901.2271.289284.13276.1
2020FY1.5201.6061.521309.22313.9
2021FY1.0401.0281.037273.42276.8
2022FY0.0100.4200.253273.42262.73
2023FY-0.370-0.190-0.366281.06279.6
2024FY-0.240-0.080-0.305231.73230.15
2025FY-2.740-2.7201.840179.02178.48
2026FY--0.500--149.15
2027FY--0.350--152.5
2028FY--0.350--156.88

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3E2026-11-11101-0.16-0.16-0.16
2026Q3E2026-11-10101-0.16-0.16-0.16
2026Q3E2026-09-24101-0.16-0.16-0.16
2026Q3E2026-06-03100-0.11-0.11-0.11
2026Q3E2026-05-15100-0.11-0.11-0.11
2026Q3E2026-04-29101-0.11-0.11-0.11
2026Q3E2026-01-271000.000.000.00
2026Q3E2025-11-111000.000.000.00
2026Q3E2025-11-101000.000.000.00
2026Q2E2026-09-24101-0.11-0.11-0.11
2026Q2E2026-06-03100-0.06-0.06-0.06
2026Q2E2026-05-15100-0.06-0.06-0.06
2026Q2E2026-04-29101-0.06-0.06-0.06
2026Q2E2026-01-271000.100.100.10

Estimate history

EPS, annual1.8251.8421.2891.5211.0370.253-0.366-0.305-2.738-1.2841
Period201720182019202020212022202320242025TTM
EPS, quarterly0.111-0.034-0.564-1.645-0.408-0.502-0.193-0.283-0.305
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual273.8283.419284.125309.215273.417256.579274.095226.972179.021160.26
Period201720182019202020212022202320242025TTM
Sales, quarterly59.5752.98446.46651.1844.36440.6642.81741.01535.77
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual20.60120.67420.16620.26920.97921.08421.14920.65721.38622.132
Period201720182019202020212022202320242025MRQ
Shares, quarterly20.66320.65620.65720.83521.01621.38321.38621.68222.132
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue160.26179.02226.97274.10256.58273.42309.21284.12283.42
Cost of Goods Sold Incl. D&A124.88138.19164.87196.38189.39198.08221.69205.14190.33
Gross Profit35.3840.8362.1077.7167.1975.3487.5278.9993.09
Selling, General and Administrative Excl. Other64.1972.2460.7384.6760.6449.6349.9348.0146.91
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-28.81-31.411.37-6.966.5525.7137.5930.9846.17
Interest Expense0.750.000.000.000.000.000.000.000.00
Unusual Expense0.0027.262.901.200.500.000.00--
Net Income Before Taxes-27.26-57.36-0.59-6.277.4527.0739.2233.8949.12
Income Taxes-0.06-0.075.681.192.315.978.618.0411.38
Consolidated Net Income-27.19-57.29-6.27-7.465.1421.1030.6025.8537.74
Net Income From Continuing Operations-27.19-57.29-6.27-7.465.1421.1030.6025.8537.74
Net Income-27.19-57.29-6.27-7.465.1421.1030.6025.8537.74
EPS (Recurring)-1.29-1.83-0.21-0.320.271.041.521.291.84
EPS (Basic, Before Extraordinaries)-1.28-2.74-0.30-0.370.251.051.531.291.84
EPS (Diluted)-1.28-2.74-0.30-0.370.251.041.521.291.84
EBITDA-19.66-22.038.410.0910.1028.4540.0133.2348.40
Non-Operating Income (Expense)2.311.310.941.891.391.361.632.922.95
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.871.08-5.205.435.233.322.412.062.45
Price To Earnings Ratio--391.59-1,400.0024.9123.1222.3211.28
Price To Sales Ratio-0.270.380.361.291.922.292.031.65
Gross Margin22.0822.8127.3628.3526.1927.5528.3027.8032.85
Operating Margin-17.98-17.550.60-2.542.559.4012.1610.9016.29
Net Margin-16.97-32.00-2.76-2.722.007.729.909.1013.32
Shares Outstanding22.1321.3920.6621.1521.0820.9820.2720.1720.67
Market Capitalization26.2326.2386.55101.29342.41541.25713.04580.38470.95

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue35.7741.0242.8240.6644.3651.1846.4752.98
Cost of Goods Sold Incl. D&A28.1531.8331.3033.6034.2339.0629.5939.66
Gross Profit7.629.1911.527.0610.1412.1216.8713.32
Selling, General and Administrative Excl. Other14.0415.4217.2117.5318.5218.9920.2013.75
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.42-6.23-5.69-10.47-8.38-6.87-3.33-0.42
Interest Expense0.200.340.000.220.330.200.000.00
Unusual Expense0.000.000.000.000.0027.262.690.03
Net Income Before Taxes-6.42-6.13-4.16-10.54-8.51-34.14-5.98-0.24
Income Taxes0.010.01-0.100.010.010.015.660.47
Consolidated Net Income-6.43-6.14-4.06-10.55-8.52-34.15-11.64-0.71
Net Income From Continuing Operations-6.43-6.14-4.06-10.55-8.52-34.15-11.64-0.71
Net Income-6.43-6.14-4.06-10.55-8.52-34.15-11.64-0.71
EPS (Recurring)-0.31-0.28-0.19-0.50-0.41-0.73-0.47-0.03
EPS (Basic, Before Extraordinaries)-0.31-0.28-0.19-0.50-0.41-1.65-0.56-0.03
EPS (Diluted)-0.31-0.28-0.19-0.50-0.41-1.65-0.56-0.03
EBITDA-4.24-4.08-3.27-8.07-6.10-4.59-1.251.16
Non-Operating Income (Expense)0.190.441.530.150.200.190.040.21
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.260.160.210.240.200.470.470.36
Price To Earnings Ratio----234.58310.28391.59-
Price To Sales Ratio-0.250.270.370.270.330.380.40
Gross Margin21.3122.3926.8917.3622.8523.6836.3125.15
Operating Margin-17.95-15.19-13.29-25.75-18.89-13.43-7.16-0.80
Net Margin-17.99-14.98-9.48-25.95-19.20-66.73-25.06-1.33
Shares Outstanding22.1321.6821.3921.3821.0220.8420.6620.66
Market Capitalization26.2341.0348.7968.3851.8568.5886.5599.60

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments21.4154.7255.30104.09111.08118.72103.76100.5377.94
Short Term Receivables1.912.323.281.741.912.593.842.542.29
Inventories13.6116.2028.5619.0232.4534.4217.8821.3723.34
Other Current Assets6.645.636.515.585.555.463.531.991.67
Total Current Assets43.5678.8793.65130.43151.00161.19129.02126.43105.23
Net Property, Plant & Equipment26.8429.8228.0926.1824.4625.4525.4527.1428.74
Total Investments and Advances5.305.305.305.000.000.000.000.000.00
Intangible Assets5.4934.7037.860.000.860.860.860.860.86
Deferred Tax Assets-0.0010.207.541.050.760.78--
Other Assets0.000.000.000.860.000.000.000.000.00
Total Assets81.19148.70175.09170.00177.37188.25156.10154.43134.84
Short Term Debt Incl. Current Port. of LT Debt0.490.460.460.000.000.000.000.000.00
Accounts Payable20.9123.5637.0225.2127.5039.5519.6616.2715.27
Income Tax Payable0.020.08---1.061.100.320.45
Other Current Liabilities30.6138.6634.6732.305.704.323.592.032.39
Total Current Liabilities52.0362.7772.1657.5133.2044.9424.3418.6318.11
Long Term Debt0.040.540.990.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.170.265.212.531.992.041.751.121.00
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities52.2563.5778.3660.0435.1946.9726.0919.7519.11
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.010.010.010.010.010.010.010.010.01
Common Equity28.9385.1296.72109.96142.18141.27130.00134.67115.72
Total Shareholders Equity28.9485.1396.73109.97142.19141.28130.01134.68115.73
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity28.9485.1396.73109.97142.19141.28130.01134.68115.73
Total Liabilities & Stockholders Equity81.19148.70175.09170.00177.37188.25156.10154.43134.84
Book Value Per Share1.354.124.575.226.786.976.456.515.62
Tangible Book Value Per Share1.102.442.785.226.746.936.406.475.58
Full-Time Employees189173287302212219214199187
Price to Book Ratio1.140.901.012.773.815.054.463.547.82
Return on Assets-49.84-3.87-4.332.9611.5417.7716.6526.0930.11
Return on Equity-100.44-6.90-7.224.0814.8922.5619.5330.1435.66
Return on Invested Capital-197.66-7.32-7.644.6714.8421.6619.8828.0232.22
Quick Ratio0.581.000.901.943.572.824.575.644.52
Current Ratio0.841.261.302.274.553.595.306.795.81

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-27.19-57.29-6.27-7.465.1421.1030.6025.8537.74
Depreciation9.169.397.047.063.552.742.432.262.23
Other Funds (Non Cash)0.4127.98-5.027.196.834.713.443.013.18
Funds from Operations-17.72-20.001.007.0813.8928.2136.7830.9743.27
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-4.97-8.393.72-2.7613.92-9.713.307.871.87
Income Taxes Payable0.120.06-0.07-1.101.960.00-0.470.470.00
Cash from Operating Activities-22.69-28.394.724.3227.8018.5040.0838.8445.14
Capital Expenditures-1.93-4.62-5.11-4.51-5.26-1.75-2.43-2.31-0.62
Net Assets From Acquisitions0.000.000.00-36.16-5.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.93-4.62-5.11-40.67-10.26-1.75-2.43-2.31-0.62
Cash Dividends Paid0.00-0.02-0.18-12.44-24.54-24.38-22.69-21.80-21.93
Change in Capital Stock0.000.000.000.000.000.000.00-11.500.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00-11.500.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.06-0.280.000.000.000.000.000.000.00
Other Financing Activities Uses-0.06-0.280.000.000.000.000.000.000.00
Cash from Financing Activities-0.06-0.30-0.18-12.44-24.54-24.38-22.69-33.30-21.93
Net Change in Cash-24.68-33.31-0.58-48.79-6.99-7.6414.963.2322.59
Free Cash Flow-24.62-33.01-0.40-0.1922.5416.7537.6436.5344.52
Price to Free Cash Flow------47.3239.1820.66
Deferred Taxes & Investment Tax Credit--0.095.250.29-1.63-0.340.31-0.150.12

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments11.4213.0821.4126.9136.1041.13
Short Term Receivables1.371.711.911.561.971.60
Inventories6.308.4713.6112.2114.7718.36
Other Current Assets6.254.356.647.836.626.80
Total Current Assets25.3427.6143.5648.5159.4567.89
Net Property, Plant & Equipment23.7525.6126.8428.1829.0829.69
Total Investments and Advances5.305.305.305.305.305.30
Intangible Assets5.015.255.495.986.476.96
Other Assets0.000.000.000.000.000.00
Total Assets59.4063.7681.1987.97100.30109.84
Short Term Debt Incl. Current Port. of LT Debt0.290.410.490.480.480.47
Accounts Payable15.2612.3020.9120.3019.1220.04
Income Tax Payable0.000.000.020.000.000.10
Other Current Liabilities26.8227.8930.6133.9837.0937.00
Total Current Liabilities42.3740.6052.0354.7756.6857.62
Long Term Debt0.000.000.040.170.290.41
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.170.170.170.260.260.26
Other Liabilities0.000.000.000.000.000.00
Total Liabilities42.5440.7752.2555.2057.2458.29
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.010.010.010.010.010.01
Common Equity16.8522.9828.9332.7643.0551.54
Total Shareholders Equity16.8622.9928.9432.7743.0651.55
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity16.8622.9928.9432.7743.0651.55
Total Liabilities & Stockholders Equity59.4063.7681.1987.97100.30109.84
Book Value Per Share0.761.061.351.532.052.47
Tangible Book Value Per Share0.540.821.101.251.742.14
Full-Time Employees--189---
Price to Book Ratio1.141.421.491.560.540.71
Return on Assets-34.05-33.73-49.84-55.74-44.67-33.65
Return on Equity-90.76-78.56-100.44-100.61-78.89-60.90
Return on Invested Capital-38.16-26.73-14.01-32.04-19.65-65.73
Quick Ratio0.450.470.580.660.790.86
Current Ratio0.600.680.840.891.051.18

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-6.43-6.14-4.06-10.55-8.52-34.15
Depreciation2.182.152.432.402.282.28
Other Funds (Non Cash)0.330.20-2.482.360.2627.84
Funds from Operations-3.93-3.80-4.20-5.79-5.98-4.03
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.87-3.89-0.54-3.413.81-8.24
Income Taxes Payable0.00-0.020.140.00-0.100.02
Cash from Operating Activities-1.06-7.69-4.74-9.21-2.17-12.27
Capital Expenditures-0.59-0.64-0.720.02-2.62-1.29
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.59-0.64-0.720.02-2.62-1.29
Cash Dividends Paid0.000.000.00-0.00-0.02-0.00
Preferred Dividends (Cash Flow)---0.00--
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.02-0.01-0.040.00-0.21-0.03
Other Financing Activities Uses-0.02-0.01-0.040.00-0.21-0.03
Cash from Financing Activities-0.02-0.01-0.040.00-0.23-0.03
Net Change in Cash-1.66-8.33-5.50-9.18-5.03-13.59
Free Cash Flow-1.64-8.33-5.46-9.18-4.80-13.56

Revenue breakdown

United States2024: 226.97M 2025: 179.02M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.76%0.8M14.4M109.82K
2026-10-156.23%0.9M14.4M111.21K
2026-09-304.81%0.7M14.4M130.84K
2026-09-153.87%0.6M14.7M630.37K
2026-08-314.44%0.6M14.6M653.06K
2026-08-143.95%0.6M14.6M669.61K
2026-07-314.50%0.7M14.6M661.05K
2026-07-156.25%0.9M14.6M667.30K
2026-06-3011.06%1.6M14.6M631.09K
2026-06-154.17%0.6M14.7M117.26K
2026-05-293.61%0.5M14.7M89.48K
2026-05-153.93%0.6M14.7M82.79K
2026-04-304.31%0.6M14.7M107.06K
2026-04-155.51%0.8M14.7M115.68K
2026-03-314.92%0.7M14.7M149.02K
2026-03-135.27%0.8M14.7M422.20K
2026-02-277.24%1.1M14.7M2.61M
2026-02-136.86%1.0M14.7M2.63M
2026-01-306.80%1.0M15.3M2.63M
2026-01-157.41%1.1M15.2M2.59M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.001.050.044.4041.000.000.261-0.0140.001
call5.000.000.050.056.0351.000.000.208-0.0170.001
call7.500.000.750.006.4580.000.000.117-0.0130.000
put2.500.901.400.004.5980.000.00-0.739-0.0140.001
put5.003.404.800.0021.0570.000.00-0.871-0.0110.000
put7.505.707.200.0019.5790.000.00-0.883-0.0120.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-064Statement of changes in beneficial ownership of securities2025-09-27SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-293Initial statement of beneficial ownership of securities2026-09-28SEC
2026-09-28S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-28S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-288-KCurrent report2026-09-27SEC
2026-09-214Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-213Initial statement of beneficial ownership of securities2026-09-17SEC
2026-09-218-KCurrent report2026-09-15SEC
2026-09-178-KCurrent report2026-09-17SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-128-KCurrent report2026-08-11SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-07-244/A2026-06-26SEC
2026-07-238-KCurrent report2026-07-23SEC
2026-06-29SCHEDULE 13D/ASEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-268-KCurrent report2026-06-23SEC
2026-06-25DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-25DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-11SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-0210-KAnnual report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-06-028-KCurrent report2026-06-02SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0643.73K100
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
RENAISSANCE TECHNOLOGIES LLC5.29%
VANGUARD CAPITAL MANAGEMENT LLC3.87%
BlackRock, Inc.2.66%
UMB Bank, n.a.1.08%
FEDERATED HERMES, INC.0.99%
STEEL PARTNERS HOLDINGS L.P.0.89%
GEODE CAPITAL MANAGEMENT, LLC0.81%
UBS Group AG0.78%
PRICE T ROWE ASSOCIATES INC /MD/0.61%
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.57%

Funds

Fund% owned
Tweedy, Browne International Value Fund58.92%
Tweedy, Browne Value Fund6.53%
Tweedy, Browne Insider + Value ETF3.56%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.82%
Tweedy, Browne International Value Fund II - Currency Unhedged2.75%
WisdomTree International SmallCap Dividend Fund2.71%
Federated Hermes MDT Small Cap Core Fund1.94%
Old Westbury Small & Mid Cap Strategies Fund1.75%
Tweedy, Browne . Buybacks . Dividends + Value Fund1.48%
Pinnacle Value Fund1.46%

OakChart. PETS. Cached 15 minutes.